Amantadine and anticholinergics

Khashayar Dashtipour, Joseph S. Chung, Allan D. Wu, Mark F. Lew

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Scopus citations

Abstract

Amantadine and anticholinergics have been used for several decades as therapy for Parkinson’s disease (PD). In spite of reduced interest in these compounds with the advent of more specific dopaminergic therapies, there remain clinical situations where amantadine and anticholinergics retain clinical usefulness and a role in the contemporary treatment of PD. In fact, in the last few years, amantadine is being prescribed more frequently to treat patients experiencing dyskinesia.

Original languageEnglish (US)
Title of host publicationHandbook of Parkinson's Disease, Fifth Edition
PublisherCRC Press
Pages373-388
Number of pages16
ISBN (Electronic)9781841849096
ISBN (Print)9781841849089
StatePublished - Jan 1 2013
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Amantadine and anticholinergics'. Together they form a unique fingerprint.

Cite this